Functional Magnetic Resonance Imaging (fMRI) is currently the main tool used for the study of function and dysfunction of the human brain. The current mainstay of fMRI, the so-called Blood-Oxygen-Level-Dependent (BOLD) contrast, capitalizes on the detection of changes in cerebral blood flow, volume and oxygenation, but cannot directly report neural activity, as it suffers from poor spatiotemporal resolution and specificity compared to the actual neural events. An alternative methodology could be that relying on the responsive, ‘smart’ contrast agents whose relaxivity depends on the concentration of substances directly related to neuronal activity. Ca2+ is an excellent marker closely linked to brain activation and is preferred target for various imaging methods. We report two Gd3+ chelates linked to a modified EGTA moiety that have a relaxivity response to extracellular Ca2+ fluctuations in the brain. The proton relaxivity of both Gd3+ complexes is sensitive to the variation of Ca2+ concentration. They are selective to Ca2+ with respect to the main competitor cation Mg2+. Upon interaction with Ca2+, the complexes exhibit high and reversible relaxivity changes; the relaxivity response of one complex upon addition of Ca2+ exceeds 80%. Moreover, the relaxivity chang